I believe that every problem has a gift. But, as a friend of mine says, sometimes the gift coming out of our problem is for others and not for us.
And a gift left for us by the 1 million people around the world who’ve died of the coronavirus is that scientists now better understand how to prevent and treat the disease — perhaps enabling millions of others to survive, says The Associated Press.
Although more deaths are expected this fall because of the recent surge in coronavirus infections in the United States and elsewhere, there also are signs that death rates are declining and that people who get the virus now are doing better than those in the early months of the pandemic.
We’re in the “stormy adolescence” phase of learning what treatments work — beyond infancy but not “all grown up either,” says Dr. Francis Collins, director of the National Institutes of Health.
While cases are rising, death rates seem to be falling, says Dr. Cyrus Shahpar, a former Centers for Disease Control and Prevention scientist now at the nonprofit group Resolve to Save Lives.
People who've died from the coronavirus, especially those who took part in studies, have helped reveal what drugs do or don't help.
Dexamethasone and similar steroids now are known to improve survival when used in hospitalized patients who need extra oxygen — but they might be harmful for less sick patients.
Remdesivir, an antiviral drug, can speed recovery for severely ill patients, cutting four days off the average hospital stay. Two anti-inflammatory drugs, one used in combination with remdesivir, also have been reported to help, although results of those studies haven't been published yet.
The jury is still out on convalescent plasma, which involves using antibody-rich blood from survivors to treat people, says AP.
The value of rigorous, scientific studies to test treatments has become clear, says Dr. Jesse Goodman, a former Food and Drug Administration chief scientist now at Georgetown University. “We certainly see what happens” when treatments are widely adopted without them as hydroxychloroquine was, he says. “That exposed a lot of people to a potentially toxic drug” and delayed the search for effective drugs.
Aside from drugs, “the case fatality rate is actually improving over time as physicians get more adept at taking care of these very sick patients,” says Dr. Gary Gibbons, director of the National Heart, Lung and Blood Institute.
In hospitals, doctors know more now about ways to avoid using breathing machines, such as keeping patients on their stomachs.
“We’ve learned about how to position patients, how to use oxygen, how to manage fluids,” and hospitals have increased their surge capacity and supplies, Dr. Judith Currier, a University of California at Los Angeles physician, said at a recent webinar organized by the American Public Health Association and the National Academy of Medicine.
The best way to avoid dying from the coronavirus continues to be to avoid getting it, and experience has shown that the simple measures advocated by public health officials work, says AP.
“Prevention is the most important step right now as we’re waiting for a vaccine and we’re improving treatment,” Goodman says.
Wearing a face mask, washing hands, keeping at least 6 feet apart and disinfecting surfaces “clearly are having a positive effect” on curbing spread, says Dr. Anthony Fauci, the nation’s top infectious disease specialist.